Pateclizumab

Pateclizumab (MLTA3698A) is an immunomodulator. It binds to lymphotoxin alpha.^{[1][2][3][4][5][6]}

Pateclizumab

Monoclonal antibody
Type	Whole antibody
Source	Humanized (from mouse)
Target	lymphotoxin alpha
Clinical data
Other names	MLTA3698A
ATC code	none
Identifiers
CAS Number	1202526-59-7 N
ChemSpider	none
UNII	QOK1YYH7J2
KEGG	D10187 N
Chemical and physical data
Formula	C6436H9910N1710O2004S44
Molar mass	144716.68 g·mol−1
NY (what is this?)  (verify)

This drug was developed by Genentech/Roche.